Tocilizumab for the Treatment of Refractory Behcet's Uveitis
Clinical trial NCT03554161 · TERMINATED
Trial details
- NCT number
- NCT03554161
- Sponsor
- Wenjie Zheng
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-10
- Primary completion
- 2021-02-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.